BUY340GSK@$46.35
- Notional
- $15,759.00
- Order type
- Limit at $46.35
GSK bid 340 @ 46.35, about 0.5% under 46.60. RSI 31, bottom 6% of the Bollinger band, 7.6% under the 50-day, -10% over 30 days. Worst day in five sessions is -2.4%, a grind, but volume is running 1.26x, so this is the marginal version of the setup and gets a patient bid. P/E 12, D/E 2.8, no earnings inside 7 days. News is a $750M blood cancer deal, Phase III flu mRNA, and the known HIV patent cliff. No downgrade or guidance cut. Not a rates bet, unlike half the scan.